• Finance

    Zoom Reports Financial Results for the Third Quarter of Fiscal Year 2022

    Third quarter total revenue of $1,050.8 million, up 35% year over year Number of customers contributing more than $100,000 in TTM revenue up 94% year over year Third quarter GAAP operating margin of 27.7% and non-GAAP operating margin of 39.1% SAN JOSE, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) — Zoom Video Communications, Inc. (NASDAQ: ZM) today announced financial results for the third fiscal quarter ended October 31, 2021. “In Q3, we held our premier user event, Zoomtopia, on our Zoom Events service. During this immersive, multi-track conference, we showcased how Zoom is placing people at the center of our communications  

    Comments Off on Zoom Reports Financial Results for the Third Quarter of Fiscal Year 2022
  • Business Analysts

    McDonald’s was the only positive in a quarter full of negatives at Beyond Meat, analysts say

    The list of problems at Beyond Meat Inc. during the third quarter was long, but the lone item on the list of good things that happened was McDonald’s Corp., analysts say. Among the troubles Beyond Meat BYND, -13.28% Chief Executive Ethan Brown mentioned on the call were: a resurgence of the delta variant; supply chain disruptions; labor shortages; the company’s reliance on business generated in stores and in-venue consumption; consumers caring less about eating healthy; and damage to packaging materials in Pennsylvania after severe weather. But on the positive side, McDonald’s MCD, -1.17% is giving the McPlant a try in  

    Comments Off on McDonald’s was the only positive in a quarter full of negatives at Beyond Meat, analysts say
  • Financial Analysis

    Century Announces Filing of Second Quarter Financial Results and Management Discussion and Analysis for Six Months Ended September 30, 2021

    THIS NEWS RELEASE IS NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO U.S. NEWS AGENCIES HONG KONG, Nov. 11, 2021 (GLOBE NEWSWIRE) — Century Global Commodities Corporation (“Century” or the “Company”) (TSX: CNT) is pleased to announce that it has filed its condensed consolidated interim financial statements for the second fiscal quarter ended September 30, 2021 and the related management discussion and analysis (“MD&A”). Copies of these documents are available under Century’s SEDAR profile at www.sedar.com and will also be posted on Century’s website at www.centuryglobal.ca. As of September 30, 2021, the Company had  

    Comments Off on Century Announces Filing of Second Quarter Financial Results and Management Discussion and Analysis for Six Months Ended September 30, 2021
  • Business Abbreviations

    Entergy Reports Third Quarter Earnings

    NEW ORLEANS, Nov. 3, 2021 /PRNewswire/ — Entergy Corporation (NYSE: ETR) reported third quarter 2021 earnings per share of $2.63 on an as-reported basis and earnings per share of $2.45 on an adjusted basis (non-GAAP). “We delivered another strong quarter. With clear visibility into the remainder of the year and a strong base plan, we are narrowing our 2021 adjusted earnings per share guidance range and affirming our longer-term outlooks.” said Entergy Chairman and Chief Executive Officer Leo Denault. “Looking forward, we are working to accelerate resilience, expand renewables, and help our customers meet their sustainability objectives.  These  

    Comments Off on Entergy Reports Third Quarter Earnings
  • Business & Finance

    PharmaTher Provides Business Update and Releases Financial Results for the First Quarter of Fiscal 2022

    TORONTO, Oct. 27, 2021 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, today released its business update and financial results for the three months ended August 31, 2021. All amounts are stated in Canadian dollars unless otherwise indicated. “To date, we have made tremendous progress across all drug programs including the initiation of our FDA Phase 2 clinical study with ketamine to treat Parkinson’s disease, the advancement of KETABET to treat depression, the FDA grant of two orphan drug designations for ketamine in the treatment of Amyotrophic Lateral Sclerosis  

    Comments Off on PharmaTher Provides Business Update and Releases Financial Results for the First Quarter of Fiscal 2022
Exit mobile version